caffeic acid phenethyl ester has been researched along with galangin in 11 studies
| Studies (caffeic acid phenethyl ester) | Trials (caffeic acid phenethyl ester) | Recent Studies (post-2010) (caffeic acid phenethyl ester) | Studies (galangin) | Trials (galangin) | Recent Studies (post-2010) (galangin) |
|---|---|---|---|---|---|
| 840 | 1 | 469 | 366 | 0 | 238 |
| Protein | Taxonomy | caffeic acid phenethyl ester (IC50) | galangin (IC50) |
|---|---|---|---|
| TPA: protein transporter TIM10 | Saccharomyces cerevisiae S288C | 35.5 | |
| TPA: protein transporter TIM23 | Saccharomyces cerevisiae S288C | 8.56 | |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | Oryctolagus cuniculus (rabbit) | 9 | |
| Cytochrome P450 1A1 | Homo sapiens (human) | 0.077 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.04 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 0.13 | |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 3.65 | |
| Xanthine dehydrogenase/oxidase | Homo sapiens (human) | 1.8 | |
| Cytochrome P450 1B1 | Homo sapiens (human) | 0.014 | |
| Aurora kinase B | Homo sapiens (human) | 9.8 | |
| Short transient receptor potential channel 5 | Homo sapiens (human) | 0.45 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Banskota, AH; Kadota, S; Matsushige, K; Midorikawa, K; Tezuka, Y; Usia, T | 1 |
| Backlund, A; Bohlin, L; Gottfries, J; Larsson, J | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Borrelli, F; Ligresti, A; Longo, R; Rossi, A; Russo, A; Sautebin, L | 1 |
| Longo, R; Russo, A; Vanella, A | 1 |
| Borrelli, F; Longo, R; Rossi, A; Russo, A; Sautebin, L | 1 |
| Borrelli, F; Capasso, F; Ialenti, A; Ianaro, A; Maffia, P; Pinto, L; Russo, A | 1 |
| Nishioka, N; Tsuji, T; Yoshizumi, K | 1 |
| Domínguez, Z; Hernandez, J; Navarro-Navarro, M; Robles-Zepeda, R; Ruiz-Bustos, E; Ruiz-Bustos, P; Valencia, D; Velazquez, C; Virués, C | 1 |
| Lohidasan, S; Mahadik, KR; Sadhana, N | 1 |
| Belduz, AO; Guler, HI; Kolayli, S; Tatar, G; Yildiz, O | 1 |
11 other study(ies) available for caffeic acid phenethyl ester and galangin
| Article | Year |
|---|---|
Constituents of Chinese propolis and their antiproliferative activities.
Topics: Animals; Antineoplastic Agents; Biphenyl Compounds; Caffeic Acids; China; Chromatography, Thin Layer; Colonic Neoplasms; Drug Screening Assays, Antitumor; Flavonoids; Free Radical Scavengers; Mice; Molecular Structure; Phenylethyl Alcohol; Picrates; Propolis; Spectrophotometry, Infrared; Tumor Cells, Cultured | 2002 |
Expanding the ChemGPS chemical space with natural products.
Topics: Biological Products; Combinatorial Chemistry Techniques; Computer Graphics; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Evaluation, Preclinical; Molecular Structure; Prostaglandin-Endoperoxide Synthases; Structure-Activity Relationship | 2005 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
The inhibitory effect of propolis and caffeic acid phenethyl ester on cyclooxygenase activity in J774 macrophages.
Topics: Animals; Caffeic Acids; Cell Line; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Dose-Response Relationship, Drug; Flavonoids; Isoenzymes; Macrophages; Phenylethyl Alcohol; Propolis; Prostaglandin-Endoperoxide Synthases | 2002 |
Antioxidant activity of propolis: role of caffeic acid phenethyl ester and galangin.
Topics: Antioxidants; Biphenyl Compounds; Caffeic Acids; Dose-Response Relationship, Drug; Flavonoids; Free Radical Scavengers; Humans; Lipid Peroxidation; Phenylethyl Alcohol; Phytotherapy; Picrates; Plant Extracts; Propolis; Xanthine Oxidase | 2002 |
The role of the phenethyl ester of caffeic acid (CAPE) in the inhibition of rat lung cyclooxygenase activity by propolis.
Topics: Animals; Anti-Inflammatory Agents; Caffeic Acids; Cyclooxygenase Inhibitors; Dinoprost; Dinoprostone; Dose-Response Relationship, Drug; Flavonoids; Inhibitory Concentration 50; Lipopolysaccharides; Lung; Male; Phenylethyl Alcohol; Phytotherapy; Plant Extracts; Propolis; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar | 2002 |
Phytochemical compounds involved in the anti-inflammatory effect of propolis extract.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Arthritis; Caffeic Acids; Carrageenan; Cell Division; Chronic Disease; Edema; Flavonoids; Male; Phenylethyl Alcohol; Phytotherapy; Plant Extracts; Pleurisy; Propolis; Rats; Rats, Inbred Lew; Rats, Wistar; T-Lymphocytes; Time Factors | 2002 |
[Xanthine oxidase inhibitory activity and hypouricemia effect of propolis in rats].
Topics: Animals; Anti-Infective Agents; Brazil; Caffeic Acids; China; Coumaric Acids; Disease Models, Animal; Flavonoids; Gout; Hyperuricemia; Male; Oxonic Acid; Phenylethyl Alcohol; Phenylpropionates; Propionates; Propolis; Rats; Rats, Sprague-Dawley; Uric Acid; Xanthine Oxidase | 2005 |
Antibacterial activity of Sonoran propolis and some of its constituents against clinically significant Vibrio species.
Topics: Anti-Bacterial Agents; Caffeic Acids; Flavonoids; Mexico; Microbial Sensitivity Tests; Phenylethyl Alcohol; Propolis; Vibrio; Vibrio cholerae O1 | 2013 |
Marker-based standardization and investigation of nutraceutical potential of Indian propolis.
Topics: Animals; Antioxidants; Bees; Caffeic Acids; Chromatography, High Pressure Liquid; Dietary Supplements; Ethanol; Flavanones; Flavonoids; Humans; India; Nutritive Value; Phenylethyl Alcohol; Plant Extracts; Polyphenols; Propolis | 2017 |
Investigation of potential inhibitor properties of ethanolic propolis extracts against ACE-II receptors for COVID-19 treatment by molecular docking study.
Topics: Angiotensin-Converting Enzyme 2; Animals; Bees; Caffeic Acids; COVID-19 Drug Treatment; Flavanones; Flavonoids; Hesperidin; Humans; Luteolin; Molecular Docking Simulation; Phenylethyl Alcohol; Plant Extracts; Propolis; Quercetin; Rutin | 2021 |